APA

Duployez N., Micol J., Boissel N., Petit A., Geffroy S., Bucci M., Lapillonne H., Renneville A., Leverger G., Ifrah N., Dombret H., Abdel-Wahab O., Jourdan E. & Preudhomme C. (20161013). Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21). : Leukemia & lymphoma.

Chicago

Duployez Nicolas, Micol Jean-Baptiste, Boissel Nicolas, Petit Arnaud, Geffroy Sandrine, Bucci Maxime, Lapillonne Hélène, Renneville Aline, Leverger Guy, Ifrah Norbert, Dombret Hervé, Abdel-Wahab Omar, Jourdan Eric and Preudhomme Claude. 20161013. Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21). : Leukemia & lymphoma.

Harvard

Duployez N., Micol J., Boissel N., Petit A., Geffroy S., Bucci M., Lapillonne H., Renneville A., Leverger G., Ifrah N., Dombret H., Abdel-Wahab O., Jourdan E. and Preudhomme C. (20161013). Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21). : Leukemia & lymphoma.

MLA

Duployez Nicolas, Micol Jean-Baptiste, Boissel Nicolas, Petit Arnaud, Geffroy Sandrine, Bucci Maxime, Lapillonne Hélène, Renneville Aline, Leverger Guy, Ifrah Norbert, Dombret Hervé, Abdel-Wahab Omar, Jourdan Eric and Preudhomme Claude. Unlike ASXL1 and ASXL2 mutations, ASXL3 mutations are rare events in acute myeloid leukemia with t(8;21). : Leukemia & lymphoma. 20161013.